InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,721.93
(
-0.70%
)
US TECH 100
19,308.40
(
-1.10%
)
Dow Jones
42,245.44
(
-0.20%
)
Brent Oil
73.83
(
2.56%
)
Bitcoin
61,825.87
(
-2.38%
)

Replies to post #4 on BioSpecifics Technologies Corp. (BSTC)

Replies to #4 on BioSpecifics Technologies Corp. (BSTC)
icon url

surf1944

05/07/12 8:07 AM

#5 RE: surf1944 #4

7:57AM On The Wires (WIRES) : BioSpecifics Technologies (BSTC) has initiated a placebo controlled randomized Phase II clinical trial, Chien-804, to evaluate the efficacy of XIAFLEX for canines with benign subcutaneous lipomas.